Presentation
9 March 2020 Fluorescence Lifetime Imaging (FLIm) for intraoperative pathology detection in transoral robotic surgery (Conference Presentation)
Author Affiliations +
Abstract
In this work, we evaluate the potential for Fluorescence Lifetime Imaging (FLIm) to complement a surgeon's visual, endoscopic, and pathologic assessment of the adequacy of intraoperative tumor resection in clinical cancer applications of the oral cavity and oropharynx. Using a custom-built FLIm instrument during both non-robotic and robotic assisted surgical procedures, we show that intrapatient contrast between healthy and tumor tissue can be achieved intraoperatively in vivo prior to cancer resection with statistical significance (p<0.001) in 9/9 patients using at least 1/6 FLIm parameters, and ex vivo for surgically excised specimens (p<0.001) for 8/9 patients. We employ a multi-parameter linear discriminant analysis approach to demonstrate superior pathology discrimination ability through leveraging a weighted combination of all FLIm metrics. We also highlight interpatient comparisons to evaluate how FLIm signatures vary across different patients and disparate tissue anatomies.
Conference Presentation
© (2020) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Brent W. Weyers, Mark Marsden, Tianchen Sun, Julien Bec, Arnaud F. Bewley, Regina F. Gandour-Edwards, Michael G. Moore, D. Gregory Farwell, and Laura Marcu "Fluorescence Lifetime Imaging (FLIm) for intraoperative pathology detection in transoral robotic surgery (Conference Presentation)", Proc. SPIE 11229, Advanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems XVIII, 1122902 (9 March 2020); https://doi.org/10.1117/12.2545150
Advertisement
Advertisement
KEYWORDS
Tissues

Pathology

Fluorescence lifetime imaging

Robotic surgery

Cancer

Tumors

Endoscopy

Back to Top